Abstract
Conventional cardiac surgical procedures after orthotopic heart transplantation are generally uncommon. We report the case of a 67-year-old man who had severe symptomatic aortic stenosis develop 9 years after heart transplantation. After joint evaluation of the cardiovascular team, transcatheter aortic valve implantation was preferred due to patient medical conditions. The CoreValve prosthesis (Medtronic, Minneapolis, MN) was inserted percutaneously into the femoral artery. At 4 months postoperatively, the patient is asymptomatic in New York Heart Association functional class II. This case report provides evidence that transcatheter aortic valve implantation is safe and suitable for selected patients with severe aortic stenosis and a history of heart transplantation that must improve allograft function.
| Original language | English |
|---|---|
| Journal | Annals of Thoracic Surgery |
| Volume | 90 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Nov 2010 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Surgery
- Pulmonary and Respiratory Medicine
- Medicine(all)
Cite this
Transcatheter aortic valve implantation after heart transplantation. / Bruschi, Giuseppe; De Marco, Federico; Oreglia, Jacopo; Colombo, Paola; Moreo, Antonella; De Chiara, Benedetta; Paino, Roberto; Frigerio, Maria; Martinelli, Luigi; Klugmann, Silvio.
In: Annals of Thoracic Surgery, Vol. 90, No. 5, 11.2010.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Transcatheter aortic valve implantation after heart transplantation
AU - Bruschi, Giuseppe
AU - De Marco, Federico
AU - Oreglia, Jacopo
AU - Colombo, Paola
AU - Moreo, Antonella
AU - De Chiara, Benedetta
AU - Paino, Roberto
AU - Frigerio, Maria
AU - Martinelli, Luigi
AU - Klugmann, Silvio
PY - 2010/11
Y1 - 2010/11
N2 - Conventional cardiac surgical procedures after orthotopic heart transplantation are generally uncommon. We report the case of a 67-year-old man who had severe symptomatic aortic stenosis develop 9 years after heart transplantation. After joint evaluation of the cardiovascular team, transcatheter aortic valve implantation was preferred due to patient medical conditions. The CoreValve prosthesis (Medtronic, Minneapolis, MN) was inserted percutaneously into the femoral artery. At 4 months postoperatively, the patient is asymptomatic in New York Heart Association functional class II. This case report provides evidence that transcatheter aortic valve implantation is safe and suitable for selected patients with severe aortic stenosis and a history of heart transplantation that must improve allograft function.
AB - Conventional cardiac surgical procedures after orthotopic heart transplantation are generally uncommon. We report the case of a 67-year-old man who had severe symptomatic aortic stenosis develop 9 years after heart transplantation. After joint evaluation of the cardiovascular team, transcatheter aortic valve implantation was preferred due to patient medical conditions. The CoreValve prosthesis (Medtronic, Minneapolis, MN) was inserted percutaneously into the femoral artery. At 4 months postoperatively, the patient is asymptomatic in New York Heart Association functional class II. This case report provides evidence that transcatheter aortic valve implantation is safe and suitable for selected patients with severe aortic stenosis and a history of heart transplantation that must improve allograft function.
UR - http://www.scopus.com/inward/record.url?scp=78049310380&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78049310380&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2010.08.021
DO - 10.1016/j.athoracsur.2010.08.021
M3 - Article
VL - 90
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
SN - 0003-4975
IS - 5
ER -